We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

IRS Misidentified $50M In Patent Litigation Costs, Mylan Says

By David Hansen · March 12, 2019, 8:12 PM EDT

The IRS wrongly denied a $50 million deduction to Mylan Inc. by incorrectly counting patent litigation costs as part of getting Food and Drug Administration approval to sell a generic drug, the...

To view the full article, register now.